skip to main content

Examining the Coverage of Pharmacogenetic Tests and Use of Pharmacogenetic Information at the Population Level


With the potential for harnessing genetic information to inform policy and coverage decisions regarding drugs, it is timely to take stock of what is known about the coverage of pharmacogenetic tests and their cost-effectiveness. 

Rapid synthesis: